Solriamfetol-based solutions for agricultural, livestock, athletic, and cognitive applications

Publication ID: 24-11857528_0002_PTD
Published: October 28, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Solriamfetol-based solutions for agricultural, livestock, athletic, and cognitive applications,” Published Technical Disclosure No. 24-11857528_0002_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857528_0002_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,528.

Summary of the Inventive Concept

The inventive concept leverages the core technology of solriamfetol therapy to develop novel applications in agriculture, livestock, athletics, and cognitive enhancement, addressing unmet needs in these fields.

Background and Problem Solved

The original patent focused on solriamfetol therapy for subjects with impaired renal function, primarily targeting excessive daytime sleepiness. However, the technology's potential extends beyond this scope. The new inventive concept addresses the limitations of the original patent by exploring novel applications that capitalize on solriamfetol's benefits.

Detailed Description of the Inventive Concept

The inventive concept comprises four primary applications: (1) a system for monitoring and managing agricultural crop yields, utilizing solriamfetol to promote plant growth; (2) a method for optimizing livestock feed formulations, adjusting solriamfetol content based on renal function to enhance feed efficiency; (3) a composition for improving exercise performance in athletes, incorporating solriamfetol to enhance bioavailability in subjects with moderate renal impairment; and (4) a method for enhancing cognitive function in individuals with ADHD, administering solriamfetol in doses adapted to renal function.

Novelty and Inventive Step

The new claims introduce novel applications of solriamfetol therapy, extending its use beyond excessive daytime sleepiness and impaired renal function. The inventive concept's novelty lies in its ability to adapt solriamfetol's benefits to diverse fields, addressing unmet needs and providing innovative solutions.

Alternative Embodiments and Variations

Alternative embodiments may include integrating solriamfetol with other compounds to enhance its effects, developing targeted delivery systems for specific applications, or exploring additional industries where solriamfetol's benefits could be leveraged.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the agricultural, livestock, athletic, and cognitive enhancement industries, offering novel solutions to pressing problems and unmet needs. The market for these applications is substantial, with potential for widespread adoption and revenue growth.

Original Patent Information

Patent NumberUS 11,857,528
TitleMethods of providing solriamfetol therapy to subjects with impaired renal function
Assignee(s)AXSOME MALTA LTD.